← Leaderboards
James H Flory
Weill Medical Coll Of Cornell Univ
$1,214,623
Attributed
$1,214,623
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $248.2K · FY2015–25$250K$187.5K$125K$62.5K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
AHRQ$759,511 · 1
NIH$455,112 · 1
By mechanism
K08$759,511 · 1
R21$455,112 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Shuibing Chen$16,196,697
- Kristy A. Brown$2,148,694
- James C Lo$6,965,639
- Yuhua Bao$5,650,344
- Santosh Bhaskar Murthy$1,182,488
Others in their field
Top investigators on “Effectiveness Outcome”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$203,539,316
- Mary M Horowitz · Medical College Of Wisconsin$179,554,727
- Judith S Hochman · New York University School Of Medicine$166,216,684
- Judith S. Currier · University Of California Los Angeles$165,962,648
Research focus
Effectiveness OutcomeElectronic Health RecordEffectivenessBlood GlucoseBlood Glucose RegulationBody Mass IndexBody WeightBody Weight ChangesBody Weight DecreasedCachexiaCancer EtiologyCessation Of LifeClinical PracticeComparative EffectivenessComparative Effectiveness ResearchContinuous Glucose MonitorDangerousnessDesire For FoodDiabetes MellitusDiagnosisDisadvantagedDrug ExposureDrug UsageElectronic Structure
Grant awards (8)
Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life$206,869
R21 · FY2025 · CA · contact PI
Managing metabolic disruption in pancreatic cancer to prevent weight loss and improve quality of life$248,243
R21 · FY2023 · CA · contact PI
Improving Metformin Utilization And Diabetes Control Through Patient-Centered Outcomes Research$151,492
K08 · FY2019 · HS · contact PI
Improving Metformin Utilization And Diabetes Control Through Patient-Centered Outcomes Research$87,629
K08 · FY2018 · HS · contact PI
Improving Metformin Utilization And Diabetes Control Through Patient-Centered Outcomes Research$64,511
K08 · FY2018 · HS · contact PI
Improving Metformin Utilization And Diabetes Control Through Patient-Centered Outcomes Research$151,902
K08 · FY2017 · HS · contact PI
Improving Metformin Utilization And Diabetes Control Through Patient-Centered Outcomes Research$151,837
K08 · FY2016 · HS · contact PI
Improving Metformin Utilization And Diabetes Control Through Patient-Centered Outcomes Research$152,140
K08 · FY2015 · HS · contact PI